Evolution of European Union legislation of herbal medicinal products and its transposition to national legislation in 1965–2007: case Finland
Article first published online: 3 DEC 2013
Copyright © 2013 John Wiley & Sons, Ltd.
The International Journal of Health Planning and Management
How to Cite
Koski, S. M., Laitinen-Parkkonen, P. and Airaksinen, M. (2013), Evolution of European Union legislation of herbal medicinal products and its transposition to national legislation in 1965–2007: case Finland. Int. J. Health Plann. Mgmt.. doi: 10.1002/hpm.2233
- Article first published online: 3 DEC 2013
- Manuscript Accepted: 18 OCT 2013
- Manuscript Revised: 22 MAY 2013
- Manuscript Received: 18 JUN 2012
- herbal medicine;
- European Union;
The study aim was to explore the progress of legislation relating to herbal medicinal products in the European Union and compare it with the corresponding progress of the legislation in Finland in 1965−2007.
The study was carried out using content analysis. Data were searched from publicly available European Union directives and national acts. All definitions and safety-related requirements for herbal medicinal products were identified. The transposition of safety-related requirements into the national legislation was studied.
Medicinal products from plant origins have been part of the European Union legislation since 1965. Most plant-based products have not initially been regarded as medicinal products but rather as some kind of medicine-like products. The official definition of herbal medicinal products was introduced in Directive 2004/24/EC and implemented into the Finnish legislation with the terminology to recognise herbal medicinal products as part of medicinal products. The current safety-related requirements of medicinal products concern analogously herbal medicinal products.
Herbal medicinal products have had different definitions in pharmaceutical legislation over the study period in the European Union and Finland. The current definition places herbal medicinal products more clearly under the medicinal products' legislation. Safety-related requirements are now practically identical for all medicinal products. Transposition of the European Union legislation into the national legislation in Finland is apparent. Copyright © 2013 John Wiley & Sons, Ltd.